Article Text

Download PDFPDF
Oxpentifylline in Parkinson's disease.
  1. R B Godwin-Austen,
  2. J A Twomey,
  3. G Hanks,
  4. J Higgins


    The effects of oxpentifylline were assessed in a double-blind trial in 11 patients with Parkinson's disease already under treatment. No significant improvement was noted. Eight patients developed involuntary movements or a worsening of movements if already present. The significance of this unexpected finding is discussed.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.